Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controversies in tocolytic therapy.

V L Katz1, R M Farmer

  • 1Center for Genetics and Maternal-Fetal Medicine, Sacred Heart Medical Center, Eugene, Oregon 97401, USA.

Clinical Obstetrics and Gynecology
|November 26, 1999
PubMed
Summary

Tocolytic agents can temporarily stop preterm labor, but magnesium sulfate is preferred over beta-mimetics. Long-term use is not recommended due to significant risks for mother and fetus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alpha-fetoprotein, prolactin and cortisol responses to maximal exercise during pregnancy.

Scandinavian journal of medicine & science in sports·2022
Same author

Two trends in middle-class birth in the United States.

Human nature (Hawthorne, N.Y.)·2013
Same author

Why we should eliminate the due date: a truth in jest.

Obstetrics and gynecology·2002
Same author

Hydrotherapy in labor.

Research in nursing & health·2001
Same author

Use of misoprostol for cervical ripening.

Southern medical journal·2000
Same author

Mycobacterium chelonae sepsis associated with long-term use of an intravenous catheter for treatment of hyperemesis gravidarum. A case report.

The Journal of reproductive medicine·2000

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine

Background:

  • Tocolytic agents are used to halt uterine contractions and delay preterm delivery.
  • The primary goal of tocolysis is to improve neonatal outcomes, often by facilitating transfer to specialized care centers and administering antenatal glucocorticoids.

Purpose of the Study:

  • To review the efficacy and safety of tocolytic agents in managing preterm labor.
  • To provide evidence-based recommendations for the appropriate use of tocolytics.

Main Methods:

  • Review of existing literature on tocolytic therapy for preterm labor.
  • Comparison of different tocolytic agents, focusing on maternal and fetal risks and benefits.

Main Results:

  • Magnesium sulfate is recommended as a first-line tocolytic agent due to a superior safety profile compared to beta-mimetics.
  • While effective in temporarily arresting labor (48-72 hours), tocolytics have not been shown to decrease the overall rate of preterm delivery.
  • Adjunctive use of indomethacin with magnesium sulfate is possible up to 32 weeks for short durations.
  • Significant long-term maternal and fetal side effects are associated with tocolytic use, precluding prolonged prophylactic administration.

Conclusions:

  • Tocolytic therapy should be used judiciously, adhering to strict guidelines, and for the shortest effective duration.
  • Maternal and fetal well-being, along with the underlying causes of preterm labor, must be continuously assessed.
  • Focus should shift towards preventing preterm labor rather than solely managing its symptoms.

Related Experiment Videos